Innovative Mesothelioma Treatment Quadruples Survival
Researchers at Queen Mary University of London have developed a groundbreaking treatment for malignant mesothelioma, significantly extending patient survival by combining a new drug, ADI-PEG20, with chemotherapy. This innovative approach offers new hope for a disease with limited treatment options, potentially changing the treatment landscape for other cancers as well.An innovative treatment significantly improves survival rates for individuals suffering from malignant mesothelioma, a rare and rapidly fatal cancer with…